Remigromig
Based on 1 Customer Validation
Remigromig (EYE-103; MK-3000) is a humanized dual-target monoclonal antibody that targets LRP5 and FZD4. Remigromig activates the Wnt/β-catenin signaling pathway by mimicking the natural ligand Norrin, induces tight junction formation and restores blood-retinal barrier function. Administered via intravitreal injection, Remigromig reduces retinal vascular leakage, and demonstrates improvements in best-corrected visual acuity and reductions in retinal thickness in studies of diabetic macular edema. Remigromig can be used for research related to macular degeneration.
For research use only. We do not sell to patients.
- Purity : 95.25%
- CAS No.: 3059389-31-7
- Molecular Weight:199.68 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Target
LRP5 & FZD4
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Frizzled-4/CD344 Protein, Human (HEK293, HY-P74140) can bind Remigromig. The ED50 for this effect is 17.22 ng/mL. -
Immobilized LRP-5 Protein, Human (HEK293, HY-P77989) can bind Remigromig. The ED50 for this effect is 891.6 ng/mL.
Product Details
-
CAS No. 3059389-31-7
-
Accession O75197 & Q9ULV1
-
Synonyms EYE-103; MK-3000
-
Molecular Weight 199.68 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
immunoglobulin [(diabody VH1-Vk2-G1(h-CH2-CH3)-VH-G1(CH1-h)_Lkappa)]_[( diabody VH2-Vk1-G1(h-CH2-CH3)-VH-G1(CH1-h)_L-kappa)]
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Purity
95.25%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Shipping
Shipping with dry ice.
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Remigromig
- 3059389-31-7
- EYE-103
- MK-3000
- EYE103
- EYE 103
- MK3000
- MK 3000
- MK-3000
- Wnt
- Wnt/β-catenin signaling
- Dutch Belted rabbits
- tight junction proteins
- blood-retina barrier
- oxygen-induced retinopathy mice
- diabetic retinopathy
- FZD4
- bEnd.3 mouse brain microvascular endothelial cells
- LRP5
- blood-brain barrier
- Inhibitor
- inhibitor
- inhibit